ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

TLPH Talphera Inc

1.04
-0.01 (-0.95%)
Last Updated: 09:31:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 7,956
Bid Price 1.03
Ask Price 1.07
News -
Day High 1.0498

Low
0.72

52 Week Range

High
1.61

Day Low 1.03
Share Name Share Symbol Market Stock Type
Talphera Inc TLPH NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.01 -0.95% 1.04 09:31:00
Open Price Low Price High Price Close Price Previous Close
1.03 1.03 1.0498 1.05
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
28 7,956 US$ 1.03 US$ 8,224 - 0.72 - 1.61
Last Trade Type Quantity Price Currency
09:30:07 998 US$ 1.04 USD

Talphera Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
17.65M 16.97M - 651k -18.4M -1.08 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Talphera News

Date Time Source News Article
5/20/202416:25PR Newswire (US)Talphera Announces Inducement Grants under Nasdaq Listing..
5/20/202416:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
5/16/202416:45PR Newswire (US)Talphera to Participate at A.G.P. Virtual Healthcare..
5/14/202416:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/14/202415:15Edgar (US Regulatory)Form 8-K - Current report
5/14/202415:05PR Newswire (US)Talphera Announces First Quarter 2024 Financial Results and..
5/02/202415:15PR Newswire (US)Talphera to Host First Quarter 2024 Financial Results Call..
3/06/202416:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/06/202415:11Edgar (US Regulatory)Form 8-K - Current report
3/06/202415:05PR Newswire (US)Talphera Announces Fourth Quarter 2023 Financial Results and..
3/04/202419:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/04/202419:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TLPH Message Board. Create One! See More Posts on TLPH Message Board See More Message Board Posts

Historical TLPH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.991.270.991.18140,8420.055.05%
1 Month0.971.270.951.1078,9120.077.22%
3 Months1.351.450.921.1271,562-0.31-22.96%
6 Months0.861.610.721.11109,0450.1820.93%
1 Year0.861.610.721.11109,0450.1820.93%
3 Years0.861.610.721.11109,0450.1820.93%
5 Years0.861.610.721.11109,0450.1820.93%

Talphera Description

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States.

Your Recent History

Delayed Upgrade Clock